Guizhou Bailing Group Pharmaceutical Co.,Ltd.’s Net Profit Rose 36.7% in First Three Quarters of 2023

Guizhou Bailing Group Pharmaceutical Co.,Ltd. (贵州百灵企业集团制药股份有限公司) (002424.SZ) reported a net profit of 140.9 million yuan in the first three quarters of 2023, up 36.7% year-on-year.

Meanwhile, the company posted 2.8 billion yuan in revenue, up 33.9% year-on-year.

At the end of the reporting period, it had 7.2 billion yuan in total assets and 3.1 billion yuan in total liabilities, with a liability-to-asset ratio of 43.4%.